Skip to content

Patient satisfaction survey on the use of VR devices for relief of discomfort symptoms in breast cancer patients

Patient satisfaction survey on the use of VR devices for relief of discomfort symptoms in breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030250017
Enrollment
180
Registered
2025-04-15
Start date
2025-05-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Research subjects view two types of VR content once using VR devices.

Sponsors

Watanabe Junichiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Is 18 years of age or older at the time of signing informed consent 2) Has a confirmed diagnosis of breast cancer 3) Is aware of any discomfort 4) Is judged by Physicians to be able to use the VR device

Exclusion criteria

Exclusion criteria: 1) Has cofnrimed diagnosis of or history of photosensitive epilepsy 2) Has difficulty in attaching, detaching, and using VR devices due to motor dysfunction 3) Has significant visual or auditory impairment and has difficulty in viewing VR contents appropriately 4) Has a history of motion sickness, visual-induced motion sickness (VIMS), magnetic field sickness, or claustrophobia that interferes with daily life, as judged by the phyisician, making paticipation in the study difficult. 5) Have hallucinations, visual hallucinations, auditory hallucinations, or have a history of the symptoms. 6) Has alcohol consumption on the day of using the VR device. 7) Is deemed ineligible to participate in this survey as judged by the physician

Design outcomes

Primary

MeasureTime frame
Satisfaction with viewing VR contents

Secondary

MeasureTime frame
1) Relationship between satisfaction with viewing VR contents and patient background factors 2) Degree of adaptation to the use of VR devices 3) Expectations regarding the effects of viewing VR contents based on patient survey 4) Presence or absence of visual-induced motion sickness (VIMS) from the use of VR devices

Contacts

Public ContactJunichiro Watanabe

Juntendo University Hospital

j.watanabe.vq@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026